A novel PGC-1α isoform in brain localizes to mitochondria and associates with PINK1 and VDAC

Biochemical and Biophysical Research Communications

Volumn 435, Issue 4, 2013, Pages 671-677

  Choi, Joungil ^a,b   Batchu, Vera Venkatanaresh Kumar ^a,b   Schubert, Manfred ^c   Castellani, Rudolph J ^a   Russell, James W ^a,b  

^a UNIVERSITY OF MARYLAND SCHOOL OF MEDICINE   (United States)

^b BALTIMORE VA MEDICAL CENTER   (United States)

^c NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE   (United States)

Author keywords

Brain; Mitochondria; PGC 1 ; PINK1; VDAC

Indexed keywords

CARBONIC ACID; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR GAMMA COACTIVATOR 1ALPHA; PHOSPHOTRANSFERASE; PROTEINASE; PTEN INDUCED PUTATIVE KINASE 1; UNCLASSIFIED DRUG; VALINOMYCIN; VOLTAGE DEPENDENT ANION CHANNEL;

ANIMAL CELL; ANIMAL TISSUE; ARTICLE; BRAIN; DEPOLARIZATION; HUMAN; HUMAN CELL; IMMUNOELECTRON MICROSCOPY; IMMUNOPRECIPITATION; IN VITRO STUDY; MEMBRANE POTENTIAL; MITOCHONDRION; MOUSE; NONHUMAN; PRIORITY JOURNAL; TISSUE DISTRIBUTION;

ANIMALS; HIPPOCAMPUS; MICE; MICE, KNOCKOUT; MITOCHONDRIA; PROTEIN ISOFORMS; PROTEIN KINASES; TISSUE DISTRIBUTION; TRANS-ACTIVATORS; VOLTAGE-DEPENDENT ANION CHANNELS;

EID: 84878979986     PISSN: 0006291X     EISSN: 10902104     Source Type: Journal    
DOI: 10.1016/j.bbrc.2013.05.041     Document Type: Article

References (15)

1. Sheng B., Wang X., Su B., Lee H.G., Casadesus G., Perry G., Zhu X. Impaired mitochondrial biogenesis contributes to mitochondrial dysfunction in Alzheimer's disease. J. Neurochem. 2012, 120:419-429.
2. Shin J.H., Ko H.S., Kang H., Lee Y., Lee Y.I., Pletinkova O., Troconso J.C., Dawson V.L., Dawson T.M. PARIS (ZNF746) repression of PGC-1alpha contributes to neurodegeneration in Parkinson's disease. Cell 2011, 144:689-702.
3. Soyal S.M., Felder T.K., Auer S., Hahne P., Oberkofler H., Witting A., Paulmichl M., Landwehrmeyer G.B., Weydt P., Patsch W. A greatly extended PPARGC1A genomic locus encodes several new brain-specific isoforms and influences Huntington disease age of onset. Hum. Mol. Genet. 2012, 21:3461-3473.
4. Benton C.R., Holloway G.P., Han X., Yoshida Y., Lally L.A., Snook J., Glatz J.F., Luiken J.J., Chabowski A., Bonen A. Increased levels of peroxisome proliferator-activated receptor gamma, coactivator 1 alpha improve lipid utilization, insulin signaling and glucose transport in skeletal muscle of lean and insulin-resistant obese Zucker rats. Diabetologia 2010, 53:2008-2019.
5. Lin J., Wu P.H., Tarr P.T., Lindenberg K.S., St-Pierre J., Zhang C.Y., Mootha V.K., Jäger S., Vianna C.R., Reznick R.M., Cui L., Manieri M., Donovan M.X., Wu Z., Cooper M.P., Fan M.C., Rohas L.M., Zavacki A.M., Cinti S., Shulman G.I., Lowell B.B., Krainc D., Spiegelman B.M. Defects in adaptive energy metabolism with CNS-linked hyperactivity in PGC-1alpha null mice. Cell 2004, 119:121-135.
6. St-Pierre J., Drori S., Uldry M., Silvaggi J.M., Rhee J., Jäger S., Handschin C., Zheng K., Lin J., Yang W., Simon D.K., Bachoo R., Spiegelman B.M. Suppression of reactive oxygen species and neurodegeneration by the PGC-1 transcriptional coactivators. Cell 2006, 127:397-408.
7. Valente E.M., Abou-Sleiman P.M., Caputo V., Muqit M.M., Harvey K., Gispert S., Ali Z., Del Turco D., Bentivoglio A.R., Healy D.G., Albanese A., Nussbaum R., González-Maldonado R., Deller T., Salvi S., Cortelli P., Gilks W.P., Latchman D.S., Harvey R.J., Dallapiccola B., Auburger G., Wood N.W. Hereditary early-onset Parkinson's disease caused by mutations in PINK1. Science 2004, 304:1158-1160.
8. Franks P.W., Scheele C., Loos R.J., Nielsen A.R., Finucane F.M., Wahlestedt C., Pedersen B.K., Wareham N.J., Timmons J.A. Genomic variants at the PINK1 locus are associated with transcript abundance and plasma nonesterified fatty acid concentrations in European whites. FASEB J. 2008, 22:3135-3145.
9. Scheele C., Nielsen A.R., Walden T.B., Sewell D.A., Fischer C.P., Brogan R.J., Petrovic N., Larsson O., Tesch P.A., Wennmalm K., Hutchinson D.S., Cannon B., Wahlestedt C., Pedersen B.K., Timmons J.A. Altered regulation of the PINK1 locus: a link between type 2 diabetes and neurodegeneration?. FASEB J. 2007, 21:3653-3665.
10. Beilina A., Van Der Brug M., Ahmad R., Kesavapany S., Miller D.W., Petsko G.A., Cookson M.R. Mutations in PTEN-induced putative kinase 1 associated with recessive parkinsonism have differential effects on protein stability. Proc. Natl. Acad. Sci. USA 2005, 102:5703-5708.
11. Gautier C.A., Kitada T., Shen J. Loss of PINK1 causes mitochondrial functional defects and increased sensitivity to oxidative stress. Proc. Natl. Acad. Sci. USA 2008, 105:11364-11369.
12. Sakamoto W., Spielewoy N., Bonnard G., Murata M., Wintz H. Mitochondrial localization of AtOXA1, an arabidopsis homologue of yeast Oxa1p involved in the insertion and assembly of protein complexes in mitochondrial inner membrane. Plant Cell Physiol. 2000, 41:1157-1163.
13. Cowell R.M., Blake K.R., Inoue T., Russell J.W. Regulation of PGC-1alpha and PGC-1alpha-responsive genes with forskolin-induced Schwann cell differentiation. Neurosci. Lett. 2008, 439:269-274.
14. Safdar A., Little J.P., Stokl A.J., Hettinga B.P., Akhtar M., Tarnopolsky M.A. Exercise increases mitochondrial PGC-1alpha content and promotes nuclear-mitochondrial cross-talk to coordinate mitochondrial biogenesis. J. Biol. Chem. 2011, 286:10605-10617.
15. Zalk R., Israelson A., Garty E.S., Azoulay-Zohar H., Shoshan-Barmatz V. Oligomeric states of the voltage-dependent anion channel and cytochrome c release from mitochondria. Biochem. J. 2005, 15:73-83.